Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Clinuvel Pharmaceuticals Ltd Sponsored ADR (Australia) · CLVLY

CLVLYOTCotherHistorical · closed Jul 20, 2026CIK 1290877Updated Nov 2, 2026

Company: Clinuvel Pharmaceuticals Ltd →

Name history
EpiTan LTD · through Mar 20, 2006
Current security for this SEC filerCLVLF · OTC

CLVLY price & chart

Provider market data
Historical security

This listing closed Jul 20, 2026. Live provider charts are shown only for current listings.

Current security: CLVLF

In the news

No coverage from other publishers is available.

Seeking Alpha

Recent filings

  1. 20-F filing

    20-F · 2026-10-30 · 0001493152-26-049364

  2. 6-K filing

    6-K · 2026-10-30 · 0001493152-26-049334

  3. 6-K filing

    6-K · 2026-10-15 · 0001493152-26-047083

  4. 6-K filing

    6-K · 2026-10-07 · 0001493152-26-046056

  5. 6-K filing

    6-K · 2026-10-02 · 0001493152-26-045459

Show 5 more recent filings
  1. 6-K filing

    6-K · 2026-10-01 · 0001493152-26-045210

  2. 6-K filing

    6-K · 2026-09-09 · 0001493152-26-041832

  3. 6-K filing

    6-K · 2026-08-27 · 0001493152-26-040352

  4. 6-K filing

    6-K · 2026-08-20 · 0001493152-26-039339

  5. 6-K filing

    6-K · 2026-08-12 · 0001493152-26-037231

Filing attachments

ex99-1.htm · 6-K · 2026-10-30

Exhibit 99.1 ASX ANNOUNkhCEMENT ASX : CUV | Nasdaq : CUVL | Börse Frankfurt: UR9 CLINUVEL files NEURACTHEL ® Instant dossier Submission of ACTH product to first European regulatory agencies Executive Summary CLINUVEL files NEURACTHEL® Instant through decentralised procedure in Europe Branded generic formulation of tetracosactide, synthetic peptide analogue of natural ACTH First national regulator reviews in three EU counties based on commercial priorities DCP requires 300 d…

6-K · 2026-10-30 · 0001493152-26-049334

Read attachment ↗
ex99-1.htm · 6-K · 2026-10-15

Exhibit 99.1

6-K · 2026-10-15 · 0001493152-26-047083

Read attachment ↗
ex99-1.htm · 6-K · 2026-10-07

Exhibit 99.1

6-K · 2026-10-07 · 0001493152-26-046056

Read attachment ↗
ex99-2.htm · 6-K · 2026-10-07

Exhibit 99.2

6-K · 2026-10-07 · 0001493152-26-046056

Read attachment ↗
ex99-1.htm · 6-K · 2026-10-02

Exhibit 99.1

6-K · 2026-10-02 · 0001493152-26-045459

Read attachment ↗
ex99-1.htm · 6-K · 2026-10-01

Exhibit 99.1 SCENESSE® response in vitiligo: new cases from the CUV105 trial presented to EADV Melbourne / Singapore - 1 October 2026 - CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced that new patient cases demonstrating the clinical response to SCENESSE® (afamelanotide) with adjunct narrowband ultraviolet B (NB-UVB) phototherapy in vitiligo patients are being presented to the European Academy of Dermatology and Venerology (EADV) conference in Vienna. Treatment effect i…

6-K · 2026-10-01 · 0001493152-26-045210

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.